PREDICTION OF THE MAXIMAL TOLERATED DOSE (MTD) AND THERAPEUTIC EFFECT OF ANTICANCER DRUGS IN HUMANS - INTEGRATION OF PHARMACOKINETICS WITH PHARMACODYNAMICS AND TOXICODYNAMICS

被引：17

作者：

FUSE, E

KOBAYASHI, T

INABA, M

SUGIYAMA, Y

机构：

[1] SANKYO CO LTD,BIOL RES LABS,SHINAGAWA KU,TOKYO 140,JAPAN

[2] JAPANESE FDN CANC RES,CTR CANC CHEMOTHERAPY,TOSHIMA KU,TOKYO 170,JAPAN

[3] UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN

来源：

关键词：

D O I：

10.1016/0305-7372(95)90024-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：133 / 157

页数：25

共 69 条

[1] BENNETT CL, 1987, CANCER RES, V47, P1952
[2] BENOWITZ N, 1974, CLIN PHARMACOL THER, V16, P87
[3] INTERSPECIES PHARMACOKINETIC SCALING AND THE EVOLUTIONARY-COMPARATIVE PARADIGM
BOXENBAUM, H
[J]. DRUG METABOLISM REVIEWS, 1984, 15 (5-6) : 1071 - 1121
[4] INTERSPECIES PHARMACOKINETIC SCALING AND THE DEDRICK PLOTS
BOXENBAUM, H
RONFELD, R
[J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 245 (06): : R768 - R775
[5] INTERSPECIES SCALING, ALLOMETRY, PHYSIOLOGICAL TIME, AND THE GROUND PLAN OF PHARMACOKINETICS
BOXENBAUM, H
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (02): : 201 - 225
[6] COLLINS JM, 1986, CANCER TREAT REP, V70, P73
[7] PHARMACOLOGICALLY GUIDED PHASE-I CLINICAL-TRIALS BASED UPON PRECLINICAL DRUG DEVELOPMENT
COLLINS, JM
GRIESHABER, CK
CHABNER, BA
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (16): : 1321 - 1326
[8] DEDRICK RL, 1970, CANCER CHEMOTH REP 1, V54, P95
[9] ANIMAL SCALE-UP
DEDRICK, RL
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (05): : 435 - 460
[10] IN-VITRO-IN-VIVO CORRELATION OF DRUG-METABOLISM - DEAMINATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE
DEDRICK, RL
FORRESTER, DD
HO, DHW
[J]. BIOCHEMICAL PHARMACOLOGY, 1972, 21 (01) : 1 - +